Streptococcus agalactiae prevalence and antimicrobial susceptibility pattern in vaginal and anorectal swabs of pregnant women at a tertiary hospital in Cameroon

BMC Research Notes
Nkembe Marius NkembePhilip Nana Njotang

Abstract

Group B Streptococcus (GBS) or Streptococcus agalactiae is part of the normal flora of the gut and genital tract, thus carrier pregnant women can transmit this germ to newborns which could cause early neonatal infection. In Cameroon, few studies have been conducted on GBS, thus this study sought to detect the rectal and vaginal colonization rates and the antibiotic susceptibility profile of the identified strains in pregnant women. We therefore conducted a cross-sectional study over a 6 months period analysing vaginal and anorectal samples obtained from 100 pregnant women. Cultures for the isolation of GBS were carried out according to standard microbiological methods and grouping done using the Pastorex strep Kit. All strains isolated were used for susceptibility test to various antibiotics as recommended by the French microbiology society, using the disk-diffusion method. The detected colonization rate was 14%. No resistance to ampicillin, oxacillin, amoxycillin-clavulanate, cefotaxime, pristinamycin, vancomycin and clindamycin was found. Just 12, 94 and 82% of strains showed sensitivity to gentamycin, erythromycin and cefoxitin respectively. This study therefore revealed that at least one out of every ten women is GBS coloni...Continue Reading

References

Dec 1, 1973·The Journal of Pediatrics·C J Baker, F F Barrett
Jul 9, 1998·The Pediatric Infectious Disease Journal·B J Stoll, A Schuchat
Dec 15, 2015·Annals of Saudi Medicine·Mubashir Ahmad KhanAhmad Mohammad Ashshi
May 26, 2016·The Pan African Medical Journal·Ahlam BassirAbderraouf Soummani
May 30, 2016·The Lancet Infectious Diseases·Gaurav KwatraShabir A Madhi

❮ Previous
Next ❯

Citations

Jul 19, 2019·Frontiers in Microbiology·Swaine L Chen
Mar 30, 2019·Annals of Clinical Microbiology and Antimicrobials·Mucheye GizachewBelay Tessema
Jun 20, 2020·Revista brasileira de ginecologia e obstetrícia : revista da Federação Brasileira das Sociedades de Ginecologia e Obstetrícia·Mina DashtizadeAli Nazari-Alam
Sep 11, 2020·Journal of Tropical Medicine·Kusum ShresthaRameshwar Adhikari

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

EPI Info

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
Jose Antonio SimoesEliane Melo Brolazo
© 2022 Meta ULC. All rights reserved